Pickering LM, et al. J Clin Oncol. 36, 2018 (suppl 6S; abstr 547).
Brigatinib bij crizotinib-refractair ALK-positief NSCLC
jun 2017 | Longoncologie
nov 2024 | Longoncologie
nov 2024 | Longoncologie
feb 2024 | Longoncologie
dec 2023 | Uro-oncologie
jun 2021 | Chirurgie, Maag-darm-leveroncologie
feb 2021 | Maag-darm-leveroncologie